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The pain is the most common problem in patients with bone metastases. It is not related to the char
acteristics of the tumor (type, location, number or size of metastases). Currently, the bone metastases can
be treated with chemotherapy, hormonal therapy, surgery and radiotherapy, but the drugs most used in
the treatment of pain are opioids. These drugs give beneﬁt between 8 and 12 weeks and often give non
negligible toxic effects. Percutaneous techniques are varied and, when there is indication, can be used to
reduce pain and dose of morphine in these patients, being safe and effective techniques already at
4 weeks of treatment.
The choice of a methodical of ablation compared to another depends on the type, size and location of the
lesion. Moreover, the combined treatments of ablation and cementoplastic are also useful to stabilize the
bone lesion.
This review article analyzes techniques and effectiveness of percutaneous treatments of skeletal
metastases.
 2008 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Painful skeletal metastases are a common problem in cancer
patients.
The causes of pain in patients with bonemetastases are not fully
understood, and the presence of pain is not correlatedwith the type
of tumor, location, number or size of metastases.
Possible mechanisms of pain include:
1. stretching of the periosteum secondary to tumor growth;
2. fractures (both micro fractures and macro fractures);
3. cytokine mediated osteoclastic bony destruction, resulting in
simulation of nerve endings in the endosteum and tumor
growth into surrounding nerves and tissues.1
Various therapies, including chemotherapy, hormonal therapy,
surgery and radiotherapy are currently used for palliative purpose.
Some patients are unable to beneﬁt from these conventional
treatments and the relief from pain, when it occurs, is not achieved
before 4d12 weeks.2t (G. Carraﬁello).
Elsevier Ltd on behalf of Surgical AWhile chemotherapy reduces primary the mass and secondary
injury in the 20 80% of patients, on the other induces drug resis
tance and resumption of bone pain and also frequent outbreaks of
myelosuppression given the toxicity of many drugs used in the
current treatment protocols.3
Hormonal therapy is effective only inmetastases from the breast
and prostate cancer.
The surgical option is reserved for those patients with patho
logical risk of fracture or spinal cord compression.
Finally, local radiotherapy is dogged in many cases by toxic
effects (nausea, vomiting and diarrhea) and radioisotope therapy
shows effectiveness in subjects with multiple bone metastases, but
on the other hand it is not regarded as standard treatment for single
metastases.4,5
Based on these considerations, analgesic drugs (opioids) are
today a ﬁrst line treatment in metastatic pain and in some cases
they remain the only alternative for palliation of symptoms.6
The side effects, especially in prolonged treatments are con
stipation, severe limitation of physical and mental status cirrhosis
and liver coma.
Several authors have studied various alternative strategies for
treating pain from bone metastases involving the use of percuta
neous imaging guided treatments with the aim of disrupt focal
bone lesions: ethanol, thermotherapy interstitial laser induced,1,7,
percutaneous radiofrequency ablation1,8–11 and, more recently,ssociates Ltd.
G. Carraﬁello et al. / International Journal of Surgery 6 (2008) S47–S52S48cryoablation, plasma mediated radiofrequency ablation1,7 and
microwave ablation.12–14
This review article will examine these ablative techniques, their
complications and effectiveness.
2. Ablative therapies for bone metastases
2.1. Pre procedural assessment
2.1.1. Imaging
The discovery of a secondary location of a solid tumor inﬂuences
diagnosis, treatment and prognosis of cancer patients, so the
detection of bone metastases assumes importance not only for the
TNM staging but also for the therapeutic address to the primary
tumor and the painful symptoms.
Scintigraphy uses the tracer Technetium 99m MDP is captured
by the bone in direct proportion to osteoblastic activity. After 3 h
we get an image representing total body functional framework of
metabolic bone. The exam is very sensitive (80 90%), but little
speciﬁc.15
The radiological examination is positive when the 30 50% of
tissue is destroyed by metastases.
Further changes including the SPECT technique and the trifasic
technique led to an increase in the speciﬁcity of skeletal
scintigraphy.
Compared to scintigraphy, conventional radiology is later in
identifying changes attributable to metastases, but more reliable
and accurate especially in terms of topographic localization. Ulti
mately, the two methods associated have a good speciﬁcity (95%).16
Conventional plain radiography is an inexpensive and conve
nient method of evaluation, sensitive in cases of destruction of
bone tissue in particular when there is cortical involvement, but
may be little sensitive in the early stages of some cancers that are
located in the spinal cord (as do the majority of metastases).17
While the CT is the best method for evaluating injuries at the
cortical, MRI is more accurate for the diagnosis of bone metastases
at sponge that has not yet altered the trabecular architecture.
The diagnostic evaluation is important to identify the corre
spondence between the area of pain indicated by the patient and
lesion highlighted by CT or MRI.18
In addition, these methods are useful as a guide during the
percutaneous procedure.
2.1.2. Assessment of quality of life
The assessment of quality of life is established after the
procedure.
There are different systems: (1) the Edmontob Symptom
Assessment System (ESAS); (2) the Townsend Functional Assess
ment Scale (TFAS); (3) morphine equivalent; and (4) a site speciﬁc
pain score (SSPS). The latter is similar to Brief Pain Inventory (BPI)
visual analog scale (VAS) score, which is mostly used in the studies
in literature.
The evaluation of pain is performedwith a VAS characterized by
a score ranging from 0 to 10, is considered moderate or severe pain
with a score equal to or greater than 4.
Usually, patients are evaluated post procedure by telephone
calls on days 1, 2 and 4 and at weeks 1, 2, 4, 8, and 12.
 The ESAS is a nine item, patient rated, symptom vertebral
rating scale with domains in global pain, nausea, tiredness,
depression, anxiety, drowsiness, appetite, sense of well being,
and shortness of breath. Each domain is scored from 0 to 10,
with higher scores representing increased disability.
 The TFAS is a functional scale. Patients are classiﬁed into four
categories: A normal pain free function, B normal functionwith pain, C signiﬁcantly limited function requiring some
type of prothesis and D non functional.
 The dose of opioid transformed into the equivalent of
morphine before and after the procedure is important to
identify variations in dosage.
Finally, the SSPS, similar to BPI, with 0 currency free from pain
and 10 worst possible pain from detention that is in motion.19
2.1.3. Inclusion criteria
The concern of selecting patients to undergo non conventional
therapies lies in an attempt to study in subjects such percutaneous
treatments could show greater effectiveness in getting the desired
result: the palliation of pain. In the literature the most accurate
criteria is provided by Callstrom et al.,11 who established that
patients with moderate or severe pain must be treated.
Pain should be limited to one or two locations corresponding to
the lesions seen on CT or MRI images. Patients with multiple
injuries may beneﬁt from a systemic therapy.
2.1.4. Exclusion criteria
Exclusion criteria are: the presence of more than two symp
tomatic lesions, the blastic nature of metastases (except for the
plasma mediated radiofrequency and cryoablation); safety
margins of less than 1 cm from the spinal cord, the motor nerve
majeure, the brain, the artery of Adamkiewicz and the bladder.203. Therapies
3.1. Percutaneous ethanol therapy
3.1.1. Technique
To provide local anesthesia a mixture of iodinated contrast
material (25%) and lidocaine 1% (75%) is injected into the area of
diffusion then a ﬁne needle is placed into the tumor. In the absence
of vascular intravasation or contact with vital structures, absolute
alcohol is then injected.21
3.1.2. Effectiveness
Gangi and colleagues described the use of CT guided percuta
neous administration of 95% ethanol for pain palliation from 27
metastatic bone lesions in 25 patients previously treated with
radiotherapy and/or chemotherapy. Sixteen lesions received
a single dose of ethanol, while 10 lesions received two doses and
one lesion received three doses. The evaluation of treatment efﬁ
cacy was assessed by the reduction in the use of analgesic medi
cines 48 h and 2 weeks following therapy. Complete relief pain was
achieved in four patients, a 75% analgesic medicine reduction was
observed in 11 patients. Seven patients received little or no relief
with the treatment.22
Alcohol diffusion into the tissues next to the tumor area could
cause necrosis by dehydration.213.2. Percutaneous laser induced interstitial thermotherapy
3.2.1. Technique
Gro¨enemeyer and colleagues reported the treatment of three
patients, with spinal metastases, using a Nd:YAG laser with
a wavelength of 1064 and the use of 400 mm optic ﬁber to deliver
energy into the lesion area.23
With local anesthesia and CT guidance, a coaxial system was
used via a transpedicular approach. Laser energy was applied at
a power of 4 10 W with a pulse length of 0.1 1.0 at 1 s intervals. In
order to achieve coverage greater than 7 mm, the ﬁber was
Fig. 1. Transverse three- dimensional volume CT image obtained at the level of
acetabular shows RF electrode deployed in a soft tissue of a metastatic lesion (arrow).
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procedure in 60 90 min.
3.2.2. Effectiveness
Three months after treatment, the patients had 45, 30, and 35%
pain reduction.23
This procedure is not adequate for treatment of very large
lesion.21
3.3. Percutaneous cryoablation
3.3.1. Technique
Cryoablation has a long history of successful treatment of
neoplasms in several organs, including prostate, kidney, liver and
the uterus. Newly developed percutaneous cryoprobes are based on
delivery of argon gas through a segmentally insulated probe, with
rapid expansion of the gas that results in rapid cooling, reaching
100 C within a few seconds.
A single cryoprobe provides an ice ball of approximately 3.5 cm
diameter. A great advantage of the cryoablation systems is that the
use of multiple cryoprobes allows the generation of large lesions by
avoiding the need to perform the time consuming overlapping
ablations needed with other ablation at the single ablation
interfaces.24
Cell death from cryoablation is due to two causes. First rapid
freezing immediately adjacent to the probe results in intracellular
ice formation and subsequent cell destruction. At a further distance
from the probe, relative gradual cooling causes osmotic differences
across the cell membrane, with secondary cellular dehydration and
death.25
This method has the advantage of being able to be used in
blastics metastases, but has the disadvantage of using a large
applicator diameter and the procedure being a long time .
3.3.2. Effectiveness
Preliminary data suggest that cryoablation is effective in treat
ing painful primary and secondary bone neoplasms [25]: 16 tumors
in 14 patients were treated with percutaneous cryoablation using
MR guidance. These investigators reported a signiﬁcant reduction
of pain in the immediate postoperative period that continued over
the long term, with associated signiﬁcant improvement of quality
of life.
The main pitfalls are the length of the procedure (about 30 min)
and the cost of the equipment. Complications depend by needle’s
access as radiofrequency procedure.
3.4. Percutaneous radiofrequency ablation (RFA)
3.4.1. Technique
The RFA is based on creation of a thermal cellular damage
converting radio waves into heat.26
The electricity generated goes from active electrode (positive) to
dispersive electrode (negative), which can be placed below the
thigh of the patient (technical monopolar) or be placed within the
active electrode (technical bipolar). The liquid contained in the cell
tissues (0.9% saline content) without any difﬁculty allows the
passage of electric current, however, by gradually increased
impedance of the tissue. The current passing in the tissues is
responsible for the phenomenon of ionic agitation and then the
production of heat from friction27 (Fig. 1).
It is obvious that the decrease of temperature tissue is directly
proportional to the distance from the (l / r 2) and that, in the light of
this, necrosis mostly those areas tissue near the electrode where
there are values of intensity current highest, moreover RFA medi
ated thermal necrosis is hampered by vascular ﬂow.28The advantage of RFA consisting of needles with relatively
smaller size compared to the other ablation devices, the disad
vantages are data from long procedures (about 30 min) and more
needle placement required for a wide area to treat.
The procedure can be performed under general anesthesia or
deep sedation with cyclical administration of alfentanyl and
mydazolam and continuous infusion of propofol is done often with
local anesthesia in the skin area of introduction of the needle.
Different types of generators and needle can be used and also
imaging guidance can be employed differently.
Bipolar technique was ﬁrst reported in 2003 in explanted and in
vivo livers. It uses one electrode thermally shielded by the opposing
second electrode, which also actively heats nearby tissue. Thus, the
heat is trapped between the two electrodes, obviating diversion of
the current from the ablation site in any direction.20
3.4.2. Effectiveness
Callstrom and colleagues,9 have demonstrated the safety and
efﬁcacy of RF for reducing pain in 12 patients, improving the quality
of life and reducing the use of analgesics in patientswithmetastases
that involved the bone. Their beneﬁt was obtained in a week.
In a recent multicenter study of Goetz10 found that 43 patients,
reported an increase in the dose of opioids on the ﬁrst day after
treatment and a subsequent decrease of over 50%.
In the latter study, there were more complications in three
patients: the ﬁrst had second degree burn in the skin of the
earthing, another had intestinal and bladder incontinence and
ﬁnally in a patient an acetabular fracture occurred in the area
treated at 6 weeks of treatment with RFA.
Kojima8 and Carraﬁello,3 analyzing in total 26 patients with 31
lesions, have obtained technical success in 100% of cases, reduction
of pain respectively in 96 and 100% of cases and a reduction of
opioids in 87 and 100% of cases.
In order to increase the accuracy of ablation in case of bone
lesions in the vicinity of organs like the spinal cord, Buy and
colleagues20 have studied the effectiveness of saline infused bipolar
radiofrequency ablation in paraspinal neoplasms.
Normal saline (0.9%) infusion has been shown to be effective in
enlarging the area of necrosis during radiofrequency ablation, acting as
Fig. 2. (a) Transverse CT contrast enhanced image shows a metastatic lesion involving the left rib (arrows). (b) Transverse CT contrast enhanced image obtained at the same level
after ablation shows a large low of attenuating area consistent with necrosis (arrows).
Fig. 3. X-plain radiograph shows a plasma-mediated radiofrequency device (arrow)
inserted in a metastatic lesion involving the right rib.
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blood and 12 15 times greater than that of soft tissue.20
In this connection, literature showed 80 95% of patients
undergoing radiofrequency ablation of bone metastases experi
enced a clinically signiﬁcant decrease in pain.9
In this connection, literature showed 80 95% of patients
undergoing radiofrequency ablation of bone metastases experi
enced a clinically signiﬁcant decrease in pain, with the complica
tion rate ranging from 0 to 6.9%9 (Figs. 2a,b).
3.5. Plasma mediated radiofrequency ablation
3.5.1. Techniques
The term coblation means ‘‘controlled ablation’’ and represents
a new generation technique for the ablation of bone lesions. It
consists of electricity liable to create a ﬁeld of ionized particles that
break the bonds within organic soft tissue (ablation). The result is
a dissolution of tissue and the formation of a cavity.
In the treatment of bone metastases, its use is justiﬁed by the
ability of method to control precisely the territory and limits of
ablation, importantly in lesions adjacent to the spinal cord or
organs abdominal or pelvic cables.
The latter, using the coblation, are less vulnerable to damage
from cellular and necrosis thermoablation.
Identifying characteristic is the ability to assign, in a very precise
way, a minimum amount of heat (unlike conventional eleetrosur
gery), which is important for example in the treatment of spinal
lesions. The low energy radiofrequency (100 KHz) is then used to
excite electrolytes in half conductive (plasma), as a saline aqueous
intracellular or the environment, to form highly ionized particles in
the area immediately adjacent to the tip of the device (Fig. 3).
The particles energized have a charge sufﬁcient to break the
molecular bonds at a relatively low temperature (from 40 to 70  C).
This process of molecular dissociation converts the tissue ablated in
gas and in this way is to create a cavity in the area of treatment. The
radiofrequency waves at a frequency exceeding 10 MHz molecular
high energy cause friction and therefore heat, which ultimately
cause necrosis damaging cells.
Ultimately the coblation uses radio frequency to ionize the
tissue and determine extensive cavitation obtaining a consequent
mass reduction on surrounding tissuewith special signs for injuriesthat result in compression on the nerve and vascular structures, the
production of that cavitation possibly allow easier injection of bone
cement for a subsequent consolidation.
For the coblation procedure is used a kit Cavity SpineWand
(ArthroCare Corp. ).
3.5.2. Effectiveness
Beneﬁts are: increased accuracy and control of the proceedings;
reduction of operating time; recovery faster and less painful;
promoting healing tissue.29
The radiofrequency plasma mediated also solves the problem of
injuries osteoblastics, as is indicated in these injuries since ‘‘making
powder’’ creating the tissue, clearly demarcated, a real cavity.
Georgy and colleagues29 and Gerszten and colleagues30 have
treated a total of 18 vertebral lesions in 18 patients and have
obtained respectively 87 and 100% in terms of a reduction of pain.
Georgy in 26% of cases (four/15 patients) had complications,
leakage of cement, without clinical consequences.
Fig. 4. Transverse CT contrast enhanced image shows the antenna (arrow) located into
the lesion of the left iliac bone. Head arrow indicates the point where microwave
energy is delivered.
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3.6.1. Technique
Microwave is a new technique using a frequency range from900 to
2450MHz and in the frequency spectrum, then ﬁts between radio
waves and infrared. Thewatermolecules are polar and electric charges
onmoleculesarenot symmetrical:hydrogenpositive, oxygennegative.
The electromagnetic radiation has an electric charge and inter
action with the molecules of water produces a series of oscillations
of the molecules themselves depending on the provision of an
ofﬁce. For a wave that has a frequency of 9.2  10. 8 Hz, the posi
tions sign change 2 billion times per second. The increase in
temperature is a measure of how fast moving molecules in
a substance upon a passage of radiation13 (Fig. 4).
For the procedure microwave generator (Valleylab) is used
and two antennas percutaneously (VT1237, Valleylab MWA).
3.6.2. Effectiveness
The beneﬁts of treatment compared with RF ablation are:
achieving high temperatures in the tumoral area (120 140 C);
a large volume of ablation for penetration of energy deeper; time
ablation faster; no dispersion of heat in the vicinity vessel.14
The methods of thermoablation with radiofrequency and
microwave have the disadvantage that it can not be used in oste
oblastics metastases.
They can also cause thermal injury to adjacent organs.
To avoid this complication, there are several options:
create an interface or air (in microwave) or with water (in RFA)
to limit the territory of ablation.
It is possible also to place thermocouples behind the structures
at risk of thermal damage, whichmeasured the temperature during
the procedure, the operator is useful in deciding whether or not to
interrupt the ablation:
use bipolar radiofrequency;20
use plasma mediated radiofrequency.29,30
Dupuy and colleagues have produced the ﬁrst experimental
studies and clinical about thermoablation with microwave in
bone metastases,13–15 quoting an excellent technical result both in
terms of volume of necrosis, and process speed, and no
complications.3.7. Combined therapies
All ablative techniques may be followed by cementoplastic
provided that it integrates the cortical bone.
The aim of this method lies in micro fractures stabilization and
reductions of mechanical forces, especially in larger lesions
destructive, lose their physiological structure.
A system is used to inject cement. The choice on the quantity of
cement to be used is made considering the measures of metastatic
lesion.
Toyota and colleagues31 stress as the procedure is easy running,
low cost, low invasive, even if they are still unknown the effects of
this combination of therapy with radiotherapy.
Twelve percent of cases had complications (hematoma) (two/
17 patients).
Schaefer and colleagues32 remember that the coagulation
necrosis induced by RFA facilitates the uniform distribution of
cementwithin the lesionwhether themethodical cementoplastic is
indispensable to obtain a decrease in bone pain and stabilization.
The results obtained in the radio frequency combined with
cementoplastic were excellent, in both case reports32–34 that in
series9,31,35,36 where the pain reduction occurred in 100% of cases
similar to As personal experience has shown, however, numerically
small.
It should be noted that, while in studies carried out only with
radio or only cementoplastic has obtained a technical success of
100% compared with a result in terms of pain reduction between 80
and 100%, from other techniques combined radio and cemento
plastic assured the reduction of pain in all cases handled, but
a technical success as a percentage slightly lower.
4. Pain relief
Regarding the ablation of bone metastases, the true goal is not
so much the complete ablation of metastases, but the reduction of
pain. Pain relief depends, directly, from needle positioning.1
Whatever the technique of ablation is used, the mechanism of
pain reduction is not yet clear, but some cases goes to the following
directions:
 destruction of sensory ﬁbers of periosteum and cortical;
 decompression mechanical volume tumor;
 destruction of tumor cells that produce cytokines such as
TNF a (tumor necrosis factor alpha) and interleukins that
promote the transmission of pain;
 inhibition of osteoclast.37,38
It is also possible that these results are obtained for synergistic
effect with conventional palliative therapies which patients were
previously screened.
In any case, many authors1,3,8–10,20 highlight the fact that the
ablative therapies and, above all, the combination therapies31–36
with cementoplasty bring a decrease in pain in 4 weeks after
treatment and a half dose opioids after a month.
5. Conclusions
Currently there are not yet common opinions onwhat is the best
method for treating bone metastases. Surely the choice of
a methodical of ablation compared to another depends on the type,
size and location of the lesion. All procedures aforementioned can
be performed in out setting patient too.
It seems clear that what justiﬁes the use of these therapies is
the fact that where there is an indication, they guarantee
a reduction of pain signiﬁcantly faster than conventional
G. Carraﬁello et al. / International Journal of Surgery 6 (2008) S47–S52S52therapies, making, in a short time, a signiﬁcant improvement in
the quality of life.Conﬂict of interest
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